HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation

NYSE:DOC • US42250P1030

Current stock price

16.685 USD
-0.01 (-0.03%)
Last:

This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DOC Profitability Analysis

1.1 Basic Checks

  • In the past year DOC was profitable.
  • DOC had a positive operating cash flow in the past year.
  • DOC had positive earnings in each of the past 5 years.
  • In the past 5 years DOC always reported a positive cash flow from operatings.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • With a Return On Assets value of 0.35%, DOC perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
  • DOC has a Return On Equity (0.94%) which is in line with its industry peers.
  • DOC's Return On Invested Capital of 2.24% is in line compared to the rest of the industry. DOC outperforms 40.98% of its industry peers.
  • DOC had an Average Return On Invested Capital over the past 3 years of 2.27%. This is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROIC 2.24%
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • DOC has a Profit Margin of 2.50%. This is comparable to the rest of the industry: DOC outperforms 46.72% of its industry peers.
  • In the last couple of years the Profit Margin of DOC has declined.
  • The Operating Margin of DOC (19.31%) is comparable to the rest of the industry.
  • DOC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of DOC (60.00%) is worse than 68.03% of its industry peers.
  • DOC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.31%
PM (TTM) 2.5%
GM 60%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DOC Health Analysis

2.1 Basic Checks

  • DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • DOC has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DOC has more shares outstanding
  • Compared to 1 year ago, DOC has a worse debt to assets ratio.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.32, we must say that DOC is in the distress zone and has some risk of bankruptcy.
  • DOC has a Altman-Z score of 0.32. This is comparable to the rest of the industry: DOC outperforms 43.44% of its industry peers.
  • DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • DOC has a Debt to Equity ratio of 1.27. This is comparable to the rest of the industry: DOC outperforms 49.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACC0.38
WACC5.94%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • DOC has a Current Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DOC has a worse Current ratio (0.48) than 74.59% of its industry peers.
  • A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.48, DOC is not doing good in the industry: 74.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DOC Growth Analysis

3.1 Past

  • DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • Measured over the past years, DOC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.06% on average per year.
  • DOC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.52%.
  • The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%

3.2 Future

  • DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
  • DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.62% yearly.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. DOC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 47.67, DOC can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as DOC.
  • DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.91.
  • DOC is valuated quite expensively with a Price/Forward Earnings ratio of 76.84.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
  • DOC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 47.67
Fwd PE 76.84
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 63.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.08
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DOC Dividend Analysis

5.1 Amount

  • DOC has a Yearly Dividend Yield of 7.35%, which is a nice return.
  • Compared to an average industry Dividend Yield of 8.03, DOC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, DOC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.35%

5.2 History

  • The dividend of DOC decreases each year by -4.20%.
  • DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B
DOC Dividend Payout.DOC Dividend Payout, showing the Payout Ratio.DOC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DOC Fundamentals: All Metrics, Ratios and Statistics

HEALTHPEAK PROPERTIES INC

NYSE:DOC (4/10/2026, 2:40:09 PM)

16.685

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02
Earnings (Next)04-22
Inst Owners97.68%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.60B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (18.85%)
Short Float %4.29%
Short Ratio3.25
Dividend
Industry RankSector Rank
Dividend Yield 7.35%
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)0%
PT rev (3m)-4.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)-0.6%
Valuation
Industry RankSector Rank
PE 47.67
Fwd PE 76.84
P/S 4.11
P/FCF N/A
P/OCF 9.27
P/B 1.55
P/tB 1.71
EV/EBITDA 13.08
EPS(TTM)0.35
EY2.1%
EPS(NY)0.22
Fwd EY1.3%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.79%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROCE 2.84%
ROIC 2.24%
ROICexc 2.3%
ROICexgc 2.51%
OM 19.31%
PM (TTM) 2.5%
GM 60%
FCFM N/A
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 130.74%
Cap/Sales 49.05%
Interest Coverage 2.1
Cash Conversion 78.06%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.32
F-Score6
WACC5.94%
ROIC/WACC0.38
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%

HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to DOC.


What is the valuation status for DOC stock?

ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.


How profitable is HEALTHPEAK PROPERTIES INC (DOC) stock?

HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.


Can you provide the financial health for DOC stock?

The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.


Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?

The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.